AGGRAVATION OF EPILEPSY ON LEVETIRACETAM THERAPY: 28 CLINICAL OBSERVATIONS, RISK FACTORS AND POSSIBILITY OF PROPHYLACTIC

by A. A. Kholin, I. D. Fedonyuk, L. M Kolpakchi, E. S. Il`ina, K. Yu. Mukhin
Published 2015-04-01

AGE-DEPENDING EFFICIENCY AND SAFETY OF TOPIRAMATE IN PATIENTS WITH DIFFERENT FORMS OF EPILEPSY

by A. A. Kholin, N. N. Zavadenko, E. S. Il'ina, I. D. Fedonyuk, L. M. Kolpakchi, V. S. Khalilov, E. S. Kosyakova
Published 2016-05-01

Early infantile epileptic encephalopathy type 4: clinical, neurophysiological and therapeutic aspects

by A. A. Kholin, N. N. Zavadenko, L. M. Kolpakchi, I. D. Fedonyuk, A. S. Papikyan, А. N. Zavadenko, E. S. Ilina
Published 2019-07-01

The efficacy and safety of nusinersen within the expanded access program in Russia

by S. B. Artemieva, L. M. Kuzenkova, E. S. Ilyina, Yu. A. Kursakova, L. M. Kolpakchi, E. Yu. Sapego, A. A. Golenko, S. G. Popovich, D. V. Parshin, O. A. Shidlovskaya, Yu. O. Papina, A. V. Monakhova, D. V. Vlodavets
Published 2020-12-01